medigraphic.com
ISSN 2007-6053 (Print)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)

2010, Number 1

<< Back Next >>

Evid Med Invest Salud 2010; 3 (1)

Convulsive status epilepticus in the adult

Gutiérrez-Manjarrez FA, García-Ramos G

Language: Spanish
References: 45
Page: 26-36
PDF size: 277.46 Kb.


ABSTRACT

Status epilepticus (SE) is considered as the maximum expression of epilepsy. This review discusses new concepts of convulsive SE, descriptions and pathophysiological impact of treatment on prognosis in the context of current best evidence available nationally and internationally. Complex partial SE and other forms of SE are not discussed in this review.


REFERENCES

  1. Kelso A. R. C, Cock H. R. Status epilepticus. Practical Neurology. 2005;5:322- 333.

  2. Browne T, Holmes G. Epilepsy. N Engl J Med. 2001;344:1145.

  3. Rubio F, Reséndiz J, Sentíes H, Alonso M, Salgado P, Ramos J. Epilepsia. Programa prioritario de epilepsia. Sector Salud. Primera edición. 2007

  4. García S, García E, Villagómez A. Una urgencia neurológica: estado epiléptico (status epilepticus). Rev Mex Neuroci. 2000;1:12-18.

  5. Drislane F. Status Epilepticus. A Clinical Perspectives. Humana Press Inc. 2005.

  6. Chen J, Wasterlain C. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 2006;5:246- 256.

  7. Bassin S, Smith T, Bleck T. Clinical review: status epilepticus. Critical Care. 2002;6:137-142.

  8. DeLorenzo R, Garnett L, Towne A. Comparison of status epilepticus with prolongad seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164- 169.

  9. Meierkord H, Holtkamp M. Non-convulsiv estatus epilepticus in adult: clinical form and treatment. Lancet Neurol. 2007;6:329-339.

  10. Murthy J. M. K. Refractory status epilepticus. Neurol India. 2006; 54:354-358.

  11. Rossetti A, Logroscino G, Bromfi eld E. Refractory status epilepticus. Effect of treatment aggressiv eness on prognosis. Arch Neurol. 2005;62:1698-1702.

  12. Mayer S, Claassen J, Lokin J, Mendelsohn F, Dennis L, Fi tzsimmons B. Refractory status epilepticus. Frecuency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205-210.

  13. Logroscino H. G, Hesdorffer D. C, Cascino G. D, Annegers J. F, Bagiella E. Long-term mortali ty after a first episode of status epilepticus. Neurology 2002;58;537-541.

  14. Wu Y. W, Shek D. W, Garcia P. A, Zhao S, Johnston S. C. Incidence and mortality of generalizad convulsive status epilepticus in California. Neurology. 2002;58:1070-1076.

  15. DeLorenzo RJ, Hauser WA , Towne AR, Boggs I, Pellock JM, Penberthy L. A prospectiv e, population-Based epidemiologic study of status epilepticus in Ri chmond Virginia. Neurology. 1996;446:1029- 1035.

  16. Hesdorffer D, Logroscino G, Cascino G, Annegers F, Hauser W. Incidence of status epilepticus in Rochester Minessota 1965-1984. Neurology. 1998;50:735- 742.

  17. Coeytaux, A. Incidence of status epilepticus in french – speaking Swi tzerland. EPISTAR . Neurology. 2000;55:693- 697.

  18. Walker M. Status epilepticus: an evidence based guide. BMJ. 2005;331:673-677.

  19. Lowenstein D, Alldredge B. Status epilepticus. N Engl J Med. 1998;338:970- 976.

  20. Mirski M, Varelas P. Seizures and status epilepticus in the critically Ill. Crit Care Clin. 2008;24:115-147.

  21. Murdoch D. Mechanism of status epilepticus: an evidence-based review. Curr Opin Neurol. 2007;20:213-216.

  22. Marik P, Varon J. The management of status epilepticus. Chest. 2004;126:582- 591.

  23. Prasad K, Krishnan P, Al-Roomi K, Sequeira R. Anticonvulsant therapy for status epilepticus. Br J Clin Pharmacol. 2007;63:640-647.

  24. Willmore J. Epilepsy emergencies. The first seizure and status epilepticus. Neurology. 1998;51:S34-S38.

  25. Urrestarazu E, Murie M, Viteri C. Manejo de la primera crisis epiléptica y del status en urgencias. An Sist Sanit Navar. 2008;31:61-73.

  26. Garzon E, França R, Ceiki A. Serial EEG Turing human status epilepticus. Evidence for PLED as anictal pattern. Neurology. 2001;57:1175-1183.

  27. Alanis M, Cruz E, Ramos J, López M. Estado epiléptico no convulsivo. Arch Neurocien. 2006;3:159-166.

  28. Holtkamp M, Othman J, Buchh eim K, Meierkord H. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology. 2006;66:1727.1729.

  29. Santos D, Vázquez F, Rodriguez X, Prieto J. Resonancia magnéti ca y estado epiléptico. Rev Neurol. 2006;43:309-310.

  30. Sirven J, Zimmerman R, Carter J, Drazkowski J, Larson J. MRI changes in status epilepticus. Neurology. 2003;60:1866.

  31. Lansberg M, O´Brien M, Norbash A, Moseley M, Morrell M, Albers G. MRI abnormalities associated with parcial status epilepticus. Neurology. 1999;52:1021-1027.

  32. Abou K, Hirsch L. Updates in the Management of seizures and status epilepticus in critically ill patients. Neurol Clin. 2008;26:385-408.

  33. Abou K, Hirsch L. Advances in the management of seizures and status epilepticus in critically ill patients. Crit Care. 2007;22:637-659.

  34. Alldredge B, Gelb A, Isaacs M, Corry M, Allen F, Ulrich S, Gottwald M, O´neil N, Neuhaus J, Segal M, Lowenstein D. A comparison of lorazepam, diazepam, and placebo for the treatment of outof- hospital status epilepticus. N Engl J Med. 2001;345:631-637.

  35. Treiman D, Meyers P, Walton N, Collins J, Colling C, Rowan J, Handforth A, Faught E, Calabrese V, Uthman B, Ramsay E, Mamdani M. A comparison of four treatments for generalizad convulsive status epilepticus. N Engl J Med. 1998;339:792-798.

  36. Claassen J, Hirsch L, Emerson R, Bates J, Thompson T, Mayer S. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsiv e status epilepticus. Neurology. 2001;57:1036-1042.

  37. Limdi N, Shimpi A, Faught E, Gomez C, Burneo J. Efficacy of rapid IV administration of valproicacid for status epilepticus. Neurology. 2005;64:353-355.

  38. Misra U, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: A pilot study. Neurology. 2006;67:340- 342.

  39. Rossetti A, Reichhart, Schaller, Despland, Bogousslavsky. New treatments for refractory status epilepticus. Epilepsia 2004;45:757-763.

  40. Abend N, Dlugos D. Treatment of refractory status epilepticus: literature review and a proponed protocol. Pediatr Neurol 2008;38:377-390.

  41. Parviainen I, Uusaro A, Kälvi äinem R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thi opental in the treatment of refractory status epilepticus in intensive care unit. Neurology. 2002;59:1249- 1251.

  42. Towne A, Garnett L, Waterhouse E, Morton L, DeLorenzo R. The use of topi ramate in refractory status epilepticus. Neurology. 2003;60:332-334.

  43. Rossetti A, Logroscino G, Bromfield E. A clinical score for prognosis of status epilepticus in adult. Neurology. 2006;66;1736-1738.

  44. Lowenstein DH. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993 ;43 :483-498.

  45. Claassen J, Loki n J, Fi tzsimmons F, Mendelsohn F, Mayer S. Predictors of functional disabi lity and mortality alter status epilepticus. Neurology. 2002;58:139-142.




2020     |     www.medigraphic.com